Currently, Jonathan David Schwartz occupies the position of Chief Medical Officer & SVP-Clinical Development at Rocket Pharmaceuticals, Inc.

In the past he occupied the position of Vice President-Clinical Development at Stemline Therapeutics, Inc., Vice President-Clinical Science at Eli Lilly & Co., Chief Medical Officer & Head-Clinical Development at Rocket Pharmaceuticals Ltd. and Associate Professor at The Mount Sinai Medical Center, Inc.

He received an undergraduate degree from Brown University and a doctorate from Washington University in St. Louis.